Tumor cells upregulates IDO1 expression and induce immune tolerance in the tumor microenvironment by depleting the essential amino acid Trp of the substrate and generating toxic metabolites such as Kyn (Takikawa et al., 1986; Routy et al., 2016; Yang et al., 2019). Here, IDO1 is linked to neoplasm.